ConductScience.org, home

Paper30191007

Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Brunt EM and 3 others. Hepat Oncol, 2015. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Papers, record 30191007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30191007

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.
PubMed
Journal
Hepat Oncol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2024-03-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brunt EMElizabeth M
2Paradis VValerie
3Sempoux CChristine
4Theise NDNeil D

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119150350EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.Gastroenterology2009https://conductscience.org/library/papers/19150350PubMed
218454509The hepatic stem cell niche: identification by label-retaining cell assay.Hepatology2008https://conductscience.org/library/papers/18454509PubMed
314556657Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence.Cancer Sci2003https://conductscience.org/library/papers/14556657PubMed
412940779Hepatic 'stem cell' malignancies in adults: four cases.Histopathology2003https://conductscience.org/library/papers/12940779PubMed
58666372Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection.Hum Pathol1996https://conductscience.org/library/papers/8666372PubMed
616879391The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.Histopathology2006https://conductscience.org/library/papers/16879391PubMed
723523670Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.Gastroenterology2013https://conductscience.org/library/papers/23523670PubMed
812170085Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.Am J Surg Pathol2002https://conductscience.org/library/papers/12170085PubMed
921344355Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.Semin Liver Dis2011https://conductscience.org/library/papers/21344355PubMed
1023958557Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.Gut2014https://conductscience.org/library/papers/23958557PubMed
1123726876Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis.Gastroenterology2013https://conductscience.org/library/papers/23726876PubMed
1221501296Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.Pathol Int2011https://conductscience.org/library/papers/21501296PubMed
1323397471Combined hepatocellular cholangiocarcinoma: a case report and review of literature.Dig Dis Sci2013https://conductscience.org/library/papers/23397471PubMed
1424633664Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy.Ann Surg Oncol2014https://conductscience.org/library/papers/24633664PubMed
152578078Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study.Cancer1985https://conductscience.org/library/papers/2578078PubMed
1618393293Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.Hepatology2008https://conductscience.org/library/papers/18393293PubMed
1712927921Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells.J Hepatol2003https://conductscience.org/library/papers/12927921PubMed
1823388123Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.Am J Surg Pathol2013https://conductscience.org/library/papers/23388123PubMed
1910870076World Health Organization classification of tumors.Cancer2000https://conductscience.org/library/papers/10870076PubMed
2011182037Clinicopathologic study on cholangiolocellular carcinoma.Oncol Rep2001https://conductscience.org/library/papers/11182037PubMed

See all 57 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
42101525Radiogenomics deciphers tumor heterogeneity in hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma.Discov Oncol2026https://conductscience.org/library/papers/42101525PubMed
40809514A Case of Combined Hepatocellular-Cholangiocarcinoma Diagnosis and Treatment With Literature Review.Clin Case Rep2025https://conductscience.org/library/papers/40809514PubMed
40502515Liver transplantation for combined hepatocellular cholangiocarcinoma: Current evidence, selection criteria, and therapeutic controversies.World J Gastrointest Surg2025https://conductscience.org/library/papers/40502515PubMed
38780656Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies.J Cancer Res Clin Oncol2024https://conductscience.org/library/papers/38780656PubMed
38278146Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.Cell Rep Med2024https://conductscience.org/library/papers/38278146PubMed
36009374Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach.Biomedicines2022https://conductscience.org/library/papers/36009374PubMed
35459975Decreased ARG1 expression as an adverse prognostic phenotype in non-alcoholic non-virus-related hepatocellular carcinoma.Virchows Arch2022https://conductscience.org/library/papers/35459975PubMed
33102226Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma.Front Oncol2020https://conductscience.org/library/papers/33102226PubMed
32729276Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.Korean J Radiol2020https://conductscience.org/library/papers/32729276PubMed
32190288Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features.Cell Biosci2020https://conductscience.org/library/papers/32190288PubMed
31654212Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.Eur Radiol2020https://conductscience.org/library/papers/31654212PubMed
30519546Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist.J Hepatocell Carcinoma2018https://conductscience.org/library/papers/30519546PubMed
30191013Hepatic stem cells and cancers: a pathologist's view.Hepat Oncol2015https://conductscience.org/library/papers/30191013PubMed
29360137cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.Hepatology2018https://conductscience.org/library/papers/29360137PubMed
29270746Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.J Huazhong Univ Sci Technolog Med Sci2017https://conductscience.org/library/papers/29270746PubMed
29131160Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.Nat Med2017https://conductscience.org/library/papers/29131160PubMed
28839428From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.World J Gastroenterol2017https://conductscience.org/library/papers/28839428PubMed
28707055Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series.Virchows Arch2017https://conductscience.org/library/papers/28707055PubMed
28261592Pathology of intrahepatic cholangiocarcinoma.Hepatobiliary Surg Nutr2017https://conductscience.org/library/papers/28261592PubMed
26441248Regenerative medicine: Hepatic progenitor cells up their game in the therapeutic stakes.Nat Rev Gastroenterol Hepatol2015https://conductscience.org/library/papers/26441248PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30191007

GET https://conductscience.org/api/papers/v1/30191007/references?page=2